{"id":"tt-infant-whole-pertussis","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions (pain, swelling, redness)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Irritability"},{"rate":null,"effect":"Drowsiness"}]},"_chembl":{"chemblId":"CHEMBL2109220","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The TT infant whole pertussis vaccine contains inactivated whole Bordetella pertussis cells that trigger both humoral (antibody) and cell-mediated immune responses in infants. This vaccine formulation was historically used as part of combination vaccines (such as DPT) to provide protection against pertussis infection. The whole-cell approach differs from acellular pertussis vaccines, which contain only specific bacterial antigens.","oneSentence":"This is a whole-cell pertussis vaccine that stimulates the immune system to produce antibodies and cellular immunity against Bordetella pertussis bacteria.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:39:11.537Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pertussis (whooping cough) prevention in infants"}]},"trialDetails":[{"nctId":"NCT06879327","phase":"PHASE2","title":"Infant Malaria Vaccine Schedule Optimization","status":"RECRUITING","sponsor":"PATH","startDate":"2025-05-30","conditions":"Malaria Vaccines","enrollment":1200},{"nctId":"NCT03606096","phase":"PHASE4","title":"Gambia Pertussis Study (GaPs)","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-01-23","conditions":"Pertussis","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"TT infant whole Pertussis","genericName":"TT infant whole Pertussis","companyName":"London School of Hygiene and Tropical Medicine","companyId":"london-school-of-hygiene-and-tropical-medicine","modality":"Biologic","firstApprovalDate":"","aiSummary":"This is a whole-cell pertussis vaccine that stimulates the immune system to produce antibodies and cellular immunity against Bordetella pertussis bacteria. Used for Pertussis (whooping cough) prevention in infants.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}